Future Goals

Developed a Comprehensive Business Plan

Created a detailed business plan outlining the innovation, market potential, competitive landscape, regulatory pathway, and commercialization strategy. This plan demonstrates a clear path to profitability and scalability.

Formed Strategic Partnerships

Collaborated with academic institutions, research organizations, hospitals, and industry partners to access expertise, resources, and infrastructure necessary for product development and validation.

Engaged Key Opinion Leaders (KOLs)

Continue to identify and engage leading experts and clinicians in relevant fields to validate the technology, provide insights into clinical needs, and potentially serve as advisors or collaborators.

Focus on Intellectual Property (IP) Protection

Secured robust intellectual property protection through patents, trademarks, or trade secrets to safeguard the innovation and establish barriers to entry for competitors. These applications are still under review.

Leverage Non-Dilutive Funding Sources

Explored opportunities for non-dilutive funding, such as government grants, research contracts, and partnerships with foundations or philanthropic organizations, to support early-stage research and development.

Demonstrate Proof of Concept

Generated compelling data demonstrating the feasibility, efficacy, and safety of the technology through preclinical studies, prototypes, or pilot clinical trials.

Built a Strong Management Team

We have assembled a team with complementary skills and expertise in areas such as scientific research, product development, regulatory affairs, and business development to execute the commercialization strategy effectively.

Seek Early-Stage Investors

We continue to target angel investors, venture capital firms specializing in life sciences or healthcare, corporate venture arms, and impact investors interested in supporting innovations with the potential to address significant unmet medical needs.

Create a Clear Investment Proposition

We have developed a compelling pitch deck and investment proposition highlighting the market opportunity, competitive advantages, milestones achieved, and the potential for significant returns on investment.

Allocate Funds Wisely

While we continue to seek for funding, we prioritize capital allocation towards critical activities such as product development, regulatory compliance, clinical validation, and market access, while minimizing unnecessary expenses to extend runway and maximize the chances of success.